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Abstract: A functional polymorphism of the gene coding for Catechol-O-methyltrasferase 
(COMT), an enzyme responsible for the degradation of the catecholamine dopamine (DA), 
epinephrine, and norepinephrine, is associated with cognitive deﬁ  cits. However, previous studies 
have not examined the effects of COMT on context processing, as measured by the AX-CPT, 
a task hypothesized to be maximally relevant to DA function. 32 individuals who were either 
healthy, with schizotypal personality disorder, or non-cluster A, personality disorder (OPD) 
were genotyped at the COMT Val158Met locus. Met/Met (n = 6), Val/Met (n = 10), Val/Val 
(n = 16) individuals were administered a neuropsychological battery, including the AX-CPT 
and the N-back working memory test. For the AX-CPT, Met/Met demonstrated more AY errors 
(reﬂ  ecting good maintenance of context) than the other genotypes, who showed equivalent error 
rates. Val/Val demonstrated disproportionately greater deterioration with increased task difﬁ  culty 
from 0-back to 1-back working memory demands as compared to Met/Met, while Val/Met did not 
differ from either genotypes. No differences were found on processing speed or verbal working 
memory. Both context processing and working memory appear related to COMT genotype and 
the AX-CPT and N-back may be most sensitive to the effects of COMT variation.
Keywords: COMT, dopamine, context processing, working memory, schizotypal personality 
disorder
Catecholamine neurotransmitter activity in the prefrontal cortex (PFC) exerts an inﬂ  u-
ence over a range of cognitive functions. Speciﬁ  cally, catechol-O-methyltransferase 
(COMT) is an important enzyme involved in the regulation of catecholamines, 
including dopamine (DA). A single nucleotide polymorphism of the gene coding 
for COMT is associated with performance with working memory (Goldberg et 
al 2003) and executive functions in schizophrenia (Egan et al 2001; Joober et al 
2002), with Val allele associated with increased enzymatic activity (leading to more 
catabolism of DA) and resultant poorer cognitive performance. In a recent study, 
Minzenberg et al (2006) demonstrated similar effects of the COMT genotype on 
cognitive performance in patients with schizotypal personality disorder (SPD). It is 
of interest that patients with SPD have been shown previously to manifest substan-
tial abnormalities on tasks highly dependent on the functioning of the prefrontal 
cortex (PFC), including the ability to maintain contextual information in short term 
memory (Barch et al 2004).Neuropsychiatric Disease and Treatment 2007:3(6) 926
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Context processing, defined as information actively 
maintained in such a form that it can be used to mediate 
later last-appropriate behavior, is particularly relevant in 
two ways. First, it has been suggested that a speciﬁ  c deﬁ  cit 
in the ability to represent and maintain context information 
may help to explain deﬁ  cits in working memory as well as 
other cognitive domains in schizophrenia and the spectrum 
disorders (Cohen and Servan-Schreiber 1992; Cohen et al 
1999). In a neuroimaging study (Barch et al 2001), working 
memory deﬁ  cits in patients with schizophrenia was shown 
to reﬂ  ect impairment in context processing associated with 
a selective disturbance in dorsolateral PFC functions.
Second, context processing has been directly linked to DA 
function, in that D-amphetamine (D-AMP), a DA agonist, 
results in improved context processing (Servan-Schreiber 
et al 1998). Recent evidence from a double-blind, placebo-
controlled trial of guanfacine treatment suggest that not only do 
patients with SPD perform more poorly on a context processing 
task than healthy control and patients with non-schizotypal 
personality disorders, pharmacological compounds increasing 
catecholamine activity in PFC exert a normalizing inﬂ  uence 
on context processing in SPD patients (McClure et al in press). 
Given its dopaminergic relevance, impaired context process-
ing may also be related to the effects of the COMT genotype. 
However, there are no published data available on the relation-
ship between COMT and context processing to date.
Tasks that measures executive functioning, such as the 
Wisconsin Card Sorting Test (WCST) (Egan et al 2001; 
Joober et al 2002; Malhotra et al 2002; Minzenberg et al 2006) 
and working memory, such as the N-back test (Goldberg et al 
2003), and, by inference, the functioning of the dorsolateral 
PFC, have been shown to be related to the COMT genotype 
in healthy and schizophrenic individuals in some studies. 
Interestingly, Mattay et al (2003) reported better performance 
in carriers of the Val allele and a decline in the Met/Met 
group in a working memory task after a pharmacological 
challenge with amphetamine. The decline in performance 
in the Met/Met group after amphetamine intake suggests 
that the association between performance and DA levels has 
an inverted “U” shape characteristic. That is, activation of 
the DA system by working memory load and amphetamine 
pushes these subjects beyond their optimal activation level. 
However, other investigators did not ﬁ  nd support that these 
tasks, presumed to be dopaminergic-depended tasks, were 
associated to COMT genotype (Tsai et al 2003; Ho et al 
2005; Minzenberg et al 2006). Speciﬁ  cally, performance on 
measures like the WCST, digit span backward subtest of the 
WAIS-III, N-back test, and Trail Making (Ho et al 2005) were 
not associated with COMT genotype in healthy individuals or 
patients with schizophrenia. Additionally, COMT genotype 
did not exert an effect on tasks measuring verbal or visual 
delayed memory in healthy and schizotypal personality 
disorder individuals (Minzenberg et al 2006).
The AX Continuous Performance Test (AX-CPT) 
(Barch et al 2004) is a task speciﬁ  cally designed to assess 
context processing. During the AX-CPT, participants are 
presented with cue-probe pairs and are told to respond to 
an “X” (probe), but only when it follows an “A” (cue). 
The task also includes three types of non-target trials that 
allow one to selectively assess context processing deﬁ  cits: 
AY trials (“A” cue followed by any letter other than “X”); 
BX trials (non-“A” cue followed by an “X” probe); and BY 
trials (non-“A” cue followed by a non-“X” probe). AX trials 
occur with high frequency (70%), creating two important 
response biases. First, this high AX frequency creates a bias 
to make a target response to any stimulus following an “A” 
cue (as a target “X” occurrence is highly likely following an 
“A” cue). In healthy individuals, maintenance of context is 
demonstrated by the tendency to make a false alarm response 
after occurrence of the “A” cue when not followed by an “X” 
(leading to increased AY errors). Conversely, low levels of 
AY errors suggest reduced tendencies toward development of 
context representations. The second bias created by the high 
AX frequency is the tendency to make a target response to 
the “X” probe, as this is the correct response the majority of 
the time. On BX trials, maintenance of the context provided 
by the cue (non-A) reduces BX false alarms. Thus, on the 
AX-CPT, deﬁ  cits in context processing are not indicated 
by an overall increase in false alarms, but rather a speciﬁ  c 
pattern of errors (decreased AY and increased BX).
In light of the current mixed ﬁ  ndings regarding the 
association between DA-dependent tasks and the effects 
of COMT genotype, it is unclear whether COMT exerts 
a general effect on poor neurocognitive functioning or a 
speciﬁ  c deﬁ  cit in one cognitive domain. Given the direct 
link to DA function and the PFC, the current study sought 
to examine whether COMT genotype variation has a speciﬁ  c 
impact on context processing. The Modiﬁ  ed AX-CPT is the 
prototypical context processing task and is hypothetically one 
of the cognitive domains that is most DA relevant, and we 
hypothesized that it may be the most relevant task that is sen-
sitive to the COMT effects, as compared to other DA-related 
tasks, including the N-back, measuring working memory, 
Trail Making, measuring processing speed and attention, and 
the Paced Auditory Serial Addition Test (PASAT) (Gronwall 
1977), measuring maintenance and manipulation processes in Neuropsychiatric Disease and Treatment 2007:3(6) 927
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verbal working memory. Previous studies have demonstrated 
that a functional genetic polymorphism of COMT inﬂ  uences 
prefrontal cognition in healthy individuals (Bruder et al 2005; 
Egan et al 2001; Malhotra et al 2002), healthy siblings of 
patients with schizophrenia spectrum disorders (Rosa et al 
2004), and patients with schizophrenia (Egan et al 2001). Fur-
ther, one published study reported that poorer performance 
on prefrontal-dependent tasks is associated with the Val/Val 
genotype regardless of diagnosis in a group of healthy indi-
viduals and patients with SPD and OPD (Minzenberg et al 
2006). Thus, in our ongoing study, we examined the shared 
effects of COMT variation on cognition in individuals with 
and without schizophrenia spectrum disorders, with the 
focus of examining tests hypothesized to be most sensitive to 
dopaminergic functions. As such, genotyping was collapsed 
across healthy individuals, patients with SPD, and patients 
with other, non-cluster A personality disorders (OPDs).
We predicted that subjects with the Val allele would show 
impairment in context processing, as evidence by a greater 
number of BX errors and a smaller number of AY errors on 
the AX-CPT, while subjects in the Met/Met group would 
demonstrate an inverse response pattern with a greater num-
ber AY errors and a smaller number of BX errors, reﬂ  ecting 
intact context processing. We also predicted that, compared to 
the Met/Met group, subjects with the Val allele would show 
impaired working memory as measured by the N-back. In 
addition to evaluating N-back accuracy score at each condition 
with different levels of difﬁ  culty, we propose that examining 
the degree of improvement that takes place from one condi-
tion to the following condition with increased difﬁ  culty would 
allow us to better understand working memory deﬁ  cit as it 
relates to COMT. We predicted that subjects with the Val allele 
would perform disproportionately worse as the task increases 
demands of working memory in comparison to the Met/Met 
group. Further, we predict that group differences in AX-CPT 
performance would yield a greater effect size, as compared to 
the N-back, suggesting that the AX-CPT is a more sensitive 
test to detect the effects on DA exerted by COMT.
Methods
Participants
As part of a larger study examining context processing 
in schizotypal personality disorder, 11 individuals with 
Diagnostic and Statistical Manual of Mental Disorders, 4th 
Edition (DSM-IV; American Psychiatric Association, 1994) 
SPD, two individuals with other, non-cluster A, DSM-IV 
personality disorders (OPD) and 19 healthy controls (HCs) 
were genotyped and evaluated on context processing and 
working memory. Participants with SPD and OPD were 
ascertained either through recruitment from the outpatient 
clinics at the Mount Sinai Medical Center and Bronx Veteran 
Affairs Medical Center, by advertisements in local newspapers, 
or by referral from psychiatrists and psychologists in the local 
community. The HCs were recruited from the local com-
munity through newspaper advertisements. Participants were 
excluded for (a) meeting criteria for current (within six months 
of testing) substance abuse or dependence, (b) a positive urine 
toxicology screen, (c) a lifetime diagnosis of a psychotic 
disorder or bipolar I disorder and (d) signiﬁ  cant head trauma. 
Participants were assessed for Axis I psychopathology using 
the Structured Clinical Interview for DSM-IV (SCID; First et 
al 1995), by a master’s level or doctoral level interviewer who 
did not know the participants’ cognitive task performance. 
In addition, participants were assessed for Axis II pathology 
using the Structured Interview for the DSM-IV Personality 
Disorders (SIDP; Pfohl et al 1995). Consensus diagnoses were 
reached in a meeting of all raters with an expert diagnostician. 
OPD individuals were excluded from the current analyses if 
they met criteria for any Cluster A personality disorder (ie, 
paranoid personality disorder, schizoid personality disorder or 
if they met more than two criteria for SPD. Healthy controls 
were excluded if they had either a personal or family history 
of a major Axis I disorder (eg, schizophrenia), or a personal 
history of an Axis II disorder. All participants signed informed 
consent forms in accordance with the approvals of Institutional 
Review Boards at each research site, where ethical approval 
for the study procedures was obtained.
Tasks and apparatus
AX-CPT tasks
Participants performed the modiﬁ  ed version of the AX-CPT, 
in which sequences of letters were visually presented one at a 
time in a continuous fashion on a computer display. Subjects 
were instructed to identify target and non-target trials with a 
button press using separate ﬁ  ngers on the same hand. Target 
trials were deﬁ  ned as a cue-probe sequence, in which the 
letter “A” appeared as the cue, and the letter “X” appeared 
as the probe. The remaining letters of the alphabet served 
as invalid cues (ie, cues that were not A’s) and non-target 
probes (ie, probes that were not X’s), with the exception of 
the letters K and Y, which were excluded due to their simi-
larity in appearance to the letter X. Letter sequences were 
presented in pseudorandom order, such that target (AX) trials 
occurred with 70% frequency, and non-target trials occurred 
with 30% frequency. Non-targets were divided evenly (10% 
each) among the following trial types: BX trials, in which Neuropsychiatric Disease and Treatment 2007:3(6) 928
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an invalid cue (ie, non-A) preceded the target; AY trials, 
in which a valid cue was followed by a non-target probe 
(ie, non-X); and BY trials, in which an invalid cue was fol-
lowed by a non-target probe. The delay between cue and 
probe was manipulated so that half of the trials had a short 
delay and half had a long delay. On short delay trials, the 
cue-probe interval was 1 sec, and the inter-trial interval was 
4900 msec. On long delay trials, the cue-probe interval was 
5 sec and the inter-trial interval was 1 sec. Thus, the total 
trial duration was equivalent across conditions, providing 
a means of controlling for general factors that might affect 
performance (eg, pace of the task, response frequency, total 
time on task). The task was presented in 4 blocks of 50 trials, 
all of which were either short (2 blocks) or long (2 blocks) 
delay trials, with the order of short and long delay blocks 
counterbalanced across subjects.
Stimuli were presented centrally, for a duration of 
300 msec, in 24-point uppercase Helvetica font. Subjects 
were instructed to respond to both cue and probe stimuli, 
pressing one button for targets and another button for 
non-targets (cues were always considered non-targets). 
Responses were recorded on a specially constructed button 
box connected to the computer that recorded response choice 
and reaction time with 1 msec accuracy. For right-handed 
individuals, responses were made with the middle (non-
target, middle button) and index (target, right button) ﬁ  ngers 
of the right hand. For left-handed individuals, responses 
were made with the middle (non-target, middle button) and 
index (target, right button) ﬁ  ngers of the left hand. Following 
previous work (Barch et al 2004), subjects were allowed a 
total of 1300 msec from stimulus onset in which to respond. 
Responses slower than this limit were not recorded, and 
elicited feedback (a “bloop” sound) as a prompt to increase 
speed. The task was run on Apple Macintosh computers, 
using PsyScope software for stimulus presentation and data 
collection (Cohen et al 1993).
N-back working memory task
The N-back is a commonly used measure of working memory 
(Braver et al 1997; Casey et al 1995; Cohen et al 1996) that 
has been frequently shown to elicit performance deﬁ  cits 
among individuals with schizophrenia and their unaffected 
relatives (Callicott et al 2000; Egan et al 2001; Menon et al 
2001; Perlstein et al 2001; Barch et al 2002; Callicott et al 
2003). The N-back test manipulates complexity with working 
memory load, rather than retention duration or interference 
conditions. Materials for the N-back task were similar to 
those used by Braver et al (1997). In the current study, 
participants observed letters presented on a computer screen 
one at a time. There were three conditions: (1) 0-back, (2) 
1-back, and (3) 2-back. In the 0-back condition, participants 
responded to a single pre-speciﬁ  ed target letter (eg, X). In 
the 1-back condition, the target was any letter identical to 
the one immediately preceding it (ie, one trial back). In the 
2-back condition, the target was any letter identical to the 
one presented 2 trials back. Thus, working memory load 
is increased incrementally from the 0-back to the 2-back 
conditions.
Stimuli were presented as single letters appearing 
centrally in 24-point Helvetica font, white against a black 
background, subtending a visual angle of approximately 
3 degrees. All consonants of the alphabet were used as stimuli 
with the exception of L (because it is easily confused with 
the number “1”) and W (because it is the only two syllable 
letter of the alphabet). Vowels were excluded. Further, the 
case of the presented lettered-stimuli changed randomly 
throughout the trials. Stimuli were presented in a pseudo-
random sequence of consonants, randomly varying in case 
in order to prevent participants from relying on strategies of 
perceptual familiarity for responding. Stimuli were presented 
centrally on a controlled computer display for 500 msec. The 
inter-stimulus interval (ISI) was 2500 msec. Targets were 
presented on 33% of the trials. Conditions were presented 
in blocks of 25 trials, with three blocks at each load level 
(0-, 1-, 2-back) presented in a counterbalanced order. The ISI 
and target density for the N-back test were selected in order 
to be consistent with prior studies using this test (Casey et al 
1995; Cohen et al 1996; Braver et al 1997).
WAIS-III vocabulary and block design
The Vocabulary and Block Design subtests of the WAIS-III 
(Wechsler, 1997) are the best correlates of overall IQ (Tulsky 
et al 1997; Wechsler 1997). These subtests were adminis-
tered to obtain an estimate of general level of intellectual 
ability.
Other neuropsychological measures
Trail Making Part A and B (Reitan and Wolfson, 1993) is a 
timed test that measures processing and psychomotor speed. 
On part A, subjects are presented with numbers from one 
to 25 randomly placed on a sheet of paper and instructed 
to connect the numbers in their correct numerical order as 
quickly as possible. Part B is analogous to Part A with the 
addition of letters and subjects are instructed to alternate 
between numbers and letters in numerical and alphabetical 
order. The PASAT (Gronwall 1977) measures maintenance Neuropsychiatric Disease and Treatment 2007:3(6) 929
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and manipulation processes in verbal working memory. On 
this test, subjects listen to a tape recorded voice presenting a 
series of numbers and are asked to add each adjacent pair of 
numbers and respond by verbalizing the sum. There are 50 
trials at a rate of one digit per two seconds, with total correct 
detections as the dependent variable.
Participants were tested in a single testing session. Task 
order was counterbalanced across participants. Prior to 
performance of the ﬁ  rst block of each computerized task, 
standardized instructions describing the task appeared 
on the computer, and the experimenter answered any 
remaining questions regarding them. Participants were 
asked to respond as quickly as possible to each stimulus 
while maintaining accuracy. One full block of trials was 
then performed as practice prior to administration of the 
experimental trials for that condition. This ensured that 
subjects understood the instructions and were performing 
the task appropriately.
COMT genotyping
Blood samples were collected from all participants and DNA 
was extracted. COMT Val108/158Met (rs4680) genotype 
was determined as a restriction fragment length polymor-
phism after polymerase chain reaction (PCR) ampliﬁ  ca-
tion from genomic DNA. DNA sequences were obtained 
from GenBank (accession no: Z26491). The sequence 
of primers and probes were as follows: forward primer, 
5′-TCGAGATCAACCCCGACTGT-3′; reserve primer, 
5′-AACGGGTCAGGCATGCA-3′; probe for Val allele, 
5′-6FAM-CCTTGTCCTTCACGCCAGCGA-3′-TAMRA; 
and probe for Met allele, 5′-VIC-ACCTTGTCCTTCAT-
GCCAGCGA-3′-TAMRA. The genotyping protocol has 
been described elsewhere (Xu et al 2002; Minzenberg 
et al 2006). Brieﬂ  y, individual genotyping was measured 
by using Applied Biosystems (ABI; Foster City, California, 
USA) 7900 Sequence Detector with a 5 μl reaction volume 
and 1–3 mg DNA. Primer concentration was 900 nmol/l for 
each primer and 100 nmol/l concentration for each probe. 
Annealing temperature was 63.5 °C with 35 cycles. Genotyp-
ing was clustered by using SDS 2.2 software (ABI). Each 
cluster represented homozygous Val allele, heterozygous 
Val/Met, Homozygous Met/Met allele and no DNA template 
control.
Data analysis
Participants were collapsed diagnostic groups for geno-
typing and analyses were conducted with group com-
parison between the different COMT genotypes for two 
reasons. First, polymorphism of COMT also influences 
prefrontal cognition in healthy individuals as well as 
schizophrenia patients, and performance on prefrontal-
dependent tasks is associated with the Val/Val genotype 
regardless of diagnosis. Second, the focus of the paper is 
to investigate the association between COMT and a task 
(ie, AX-CPT) hypothesized to be maximally relevant 
to DA function. For the AX-CPT, analyses focused on 
error rates for the two error types most related to effec-
tive context processing, BX and AY, for both the short 
and long delay intervals. Context processing data were 
analyzed using analyses of variance (ANOVAs) with 
genotype as a between-subject factor and trial type and 
delay as within-subject factors. For the N-back, accu-
racy scores were calculated for each participant across 
the three conditions (0-back, 1-back, 2-back). ANOVAs 
were conducted to examine the accuracy responses from 
the N-back with genotype as a between-subject factor 
and condition as a within-subject factor. Additionally, 
change scores were calculated to capture changes in per-
formance as the N-back test increased in difficulty from 0 
to 1-back and 1 to 2-back. While accuracy scores provide 
information on performance level at each task condition, 
change scores would yield additional information regard-
ing the proportion of worsening as load increased in the 
task Greater changes indicate greater vulnerability to 
increases in processing demands. A series of Univariate 
ANOVAs were conducted to examine changes in perfor-
mance with genotype as the between-subject factor and 
change scores as the dependent variable. For all posthoc 
analyses, planned contrasts were conducted for multiple 
pairwise comparisons and Bonferroni was used to adjust 
for the alpha level.
Results
Demographic information
Three groups of COMT genotypes were identiﬁ  ed, includ-
ing Met/Met (n = 6), Val/Met (n = 10) and Val/Val (n = 16). 
Demographic characteristics of the genotype groups are 
shown in Table 1. One participant has missing demographic 
data. The genotypes did not differ on age, F(2, 28) = 0.60, 
p = 0.56, education, F(2, 28) = 0.56, p = 0.58, ethnicity, 
χ2(8) = 7.55, p = 0.48, gender composition, χ2(2) = 0.02, 
p = 0.99, or estimated IQ as measured by WAIS Vocabulary, 
F(2, 28) = 0.65, p = 0.53 or Block Design, F(2, 27) = 1.20, 
p = 0.32. The majority of the participants (84.4%) were right-
handed individuals, but again, the genotypes did not differ 
on handedness, χ2(2) = 1.40, p = 0.50.Neuropsychiatric Disease and Treatment 2007:3(6) 930
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Effects of COMT genotype on context 
processing
For the purposes of this study, we will focus on main effects 
of genotype or interaction with genotype in all of the analyses 
presented below, as our hypotheses focused on genotypic 
differences. The error data from the AX-CPT was analyzed 
using a 3-factor ANOVA, with genotype (Met/Met, Val/Met, 
Val/Val) as a between-subject factor, and both delay (short, 
long) and error type (AX, AY, BX, BY) as within-subject 
factors. Descriptive statistics for the AX-CPT are presented 
in Table 2. The ANOVA did not reveal a signiﬁ  cant main 
effect of genotype, F(2, 29) = 0.54, p = 0.59. However, there 
was a non-signiﬁ  cant trend for an error type by genotype 
interaction, F(6, 56) = 2.06, p = 0.07, with the Val/Val group 
making more BX than AY errors, while the Val/Met and 
Met/Met groups made more AY and BX errors. Given our 
small sample sizes, we followed up the interaction although 
it was nonsigniﬁ  cant.
Follow up univariate ANOVAs showed a signiﬁ  cant 
genotype difference in AY errors during the short delay 
condition, F(2, 29) = 3.77, p   0.05, R2 = 0.21. Compared to 
Met/Met, Val/Met (p   0.05) and Val/Val (p  0.05) made 
signiﬁ  cantly fewer AY errors, but Val/Met and Val/Val did 
not differ. Similarly, there was also a signiﬁ  cant genotype 
difference in AY errors during the long delay F(2, 29) = 
3.69), p   0.05, R2 = 0.20, with Met/Met making more AY 
errors compare to the Val/Val (p   0.05) while the Val/Met 
did not differ from the other two groups (p   0.05). There 
were no genotype differences in BX errors during the short 
F(2, 29) = 0.12, p = 0.89, or long F(2, 29) = 0.51, p = 0.61 
delay. These results suggest that although the groups did not 
differ on BX false alarms, Met/Met subjects demonstrated 
better maintenance of context relative to Val/Met and Met/
Met subjects, as reﬂ  ected by the AY errors.
Effects of COMT genotype on working 
memory
The accuracy data from the N-back were analyzed using a 2-
factor ANOVA with genotype (Met/Met, Val/Met, Val/Val) 
as a between subject factor and condition (0-back, 1-back, 
2-back) as a within-subject factor. A signiﬁ  cant main effect 
of condition was found, F(2, 28) = 8.21, p   0.01, but there 
was no signiﬁ  cant main effect of genotype, F(2, 29) = 0.61, 
p = 0.55, or interaction, F(4, 58) = 1.74, p = 0.15. As dis-
played on Table 3, participants performed the worst at 2-back 
compared to the other two conditions (p’s   0.01), though 
there were no differences in performance between 0-back 
and 1-back (p  0.05).
Genotype comparison analyses were conducted to exam-
ine changes in performance as the task increased in difﬁ  culty 
(ie, the difference in accuracy score from one condition to 
another). This mechanism would provide more meaning 
information on differential deterioration as the task becomes 
more demanding. Change scores were calculated to capture 
changes in performance from 0-back to 1-back, 1-back to 
2-back, and 0-back to 2-back. The ANOVA revealed a sig-
niﬁ  cant genotype difference in performance from 0-back to 
1-back, F(2, 29) = 3.66, p 0.05), R2 = 0.20. As shown in 
Figure 1, Val/Val subjects had a greater change score com-
pared to Met/Met subjects (p  0.05), suggesting a greater 
Table 1 Sample characteristics
 Group
 Met/Met  Val/Met  Val/Val
  M SD  M SD  M  SD
Age  (in  years)  31.7 10.7 31.0 11.4 35.8  10.8
Sex (% male)  66.7  -  70.0  -  68.8  -
Handedness (% right)  100  -  88.9  -  81.3  -
Education (in years)  16.1  2.6  16.7  4.1  15.1  3.7
Vocabulary  scores  9.8 2.4 10.2  2.7 11.13  2.6
Block design scores  12.0  3.0  12.7  3.7  10.6  3.1
Table 3 N-back working memory accuracy scores
 Group
 Met/Met  Val/Met  Val/Val
  M (SD)  M (SD)  M (SD)
0-back  88.9 (11.0)  94.7 (5.8)  97.9 (1.6)
1-back  92.5  (8.6) 92.7  (5.9) 92.8  (6.4)
2-back  86.4 (5.2)  88.0 (12.1)  86.7 (9.6)
Note: Response data are proportion of correct responses.
Table 2 Standard AX-CPT errors
 Group
 Met/Met  Val/Met  Val/Val
Error type  M (SD)  M (SD)  M (SD)
Short delay     
AX  3.8  (6.5) 1.4  (1.5) 1.6  (3.3)
AY  20.0 (26.8)  4.0 (7.0)  4.4 (6.4)
BX  3.3  (5.2) 5.3  (7.7) 7.5  (25.2)
BY  1.7  (4.1) 2.3  (4.8) 2.0  (4.4
Long delay     
AX  20.1 (25.9)  7.6 (11.6)  11.8 (20.0)
AY  16.7 (24.2)  11.2 (11.2)  1.9 (5.4)
BX  3.5 (5.5)  11.4 (15.5)  13.3 (25.5)
BY  0.0  (0.0) 0.0  (0.0) 1.4  (5.6)
Note: Error data are proportions of errors.Neuropsychiatric Disease and Treatment 2007:3(6) 931
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deterioration going from 0- to 1-back, while Val/Met subjects 
did not differ from the other groups. There were no signiﬁ  cant 
genotype differences in change of performance from 1- to 
2-back F(2, 29) = 0.12, p = 0.89, or 0- to 2-back, F(2, 29) = 
2.04, p = 0.15, although the Val/Val group clearly showed 
the largest deterioration from 0 to 2 back.
Effects of COMT genotype on other 
PFC indices
A series of ANOVAs were conducted to examine genotype 
group differences on processing speed, as indexed by Trails 
Making A and B, and verbal working memory, as indexed 
by the PASAT. One subject from the Val/Met genotype had 
missing data on these measures and was not included in these 
analyses. The genotypes did not differ on Trail Making part 
A, F(2, 28) = 3.32, p = 0.51, Trail Making part B, F(2, 28) = 
2.24, p = 0.13, or the PASAT, F(2, 28) = 0.29, p = 0.75.
Discussion
The goal of the current study was to examine the effects 
of COMT genotype on context processing, as well as to 
replicate previous ﬁ  ndings of working memory deﬁ  cit in 
carriers of the Val allele. We predicted that the Val/Met and 
Val/Val genotypes would demonstrate impairment in context 
processing, and that this impairment would not be found in 
the Met/Met group.
In the modiﬁ  ed AX-CPT context processing is best 
understood by the pattern of errors, rather than the overall 
number of errors, that an individual makes. Speciﬁ  cally, 
a greater number of AY errors suggest development of 
a response bias reﬂ  ecting intact context processing and 
individuals with intact context processing tend to make a 
smaller number of BX errors. Impaired context process-
ing, on the other hand, is indicated by the reverse pattern: 
greater numbers of BX and smaller numbers of AY errors. 
While we did not ﬁ  nd a main effect of genotype, there was 
a non-signiﬁ  cant trend for a genotype by condition interac-
tion. This is likely due to the low statistical power as a result 
of the small sample size because additional post-hoc tests 
showed that, during both the short and long delays of the 
AX-CPT, participants in the Met/Met group demonstrated a 




















Figure 1 Proportions of change in performance on the n-back test as captured by difference scores from 0- to 1-back, 1- to 2-back and 0- to 2-back. Note: Larger change 
score indicates a greater decrease in accuracy as the condition increased in difﬁ  culty because performance is expected to be worse as the more demanding condition 
(ie, 1-back) relative to the less demanding condition (ie, 0-back). *Val/Val subjects demonstrated a greater change score compared to Met/Met subjects, p   0.05.Neuropsychiatric Disease and Treatment 2007:3(6) 932
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groups. Further, COMT genotype accounted for 20%–21% 
of variance in AX-CPT performance which is substantial 
compared to previous results of shared variance with other 
cognitive tests (Egan et al 2001; Malhotra et al 2002). There 
were, however, no differences in the number of BX errors in 
either the short or long delay condition, which is interesting 
in the context of the recent results of McClure et al (2006). In 
that study we found that the beneﬁ  cial effects of guanfacine, 
an adrenergic agonist, were greater on AY than BX errors. 
In a study examining executive functioning and COMT, 
Egan et al (2001) reported that COMT genotype accounted 
for 4% of the variance in frequency of preseverative errors 
on the WCST, while the current study found that COMT 
genotype accounted for about 20% of the variance on the 
AX-CPT. This ﬁ  nding is quite robust and is consistent with 
our hypothesis that the AX-CPT is dopaminergic task that 
is sensitive to the effects of COMT. In support of the idea 
that the small sample that we collected is still representative, 
the Met/Met group in our sample demonstrated an average 
of AY error rate of 18.3%, which is similar, albeit slightly 
larger, to the rates reported by McDonald et al (2003) and 
Barch et al (2001), Thus, the larger variance accounted for 
statistics may truly reﬂ  ect differences in task sensitivity to 
dopaminergic effects.
Although we did not ﬁ  nd genotype differences in perfor-
mance on the N-back working memory test when accuracy 
scores were analyzed at each condition of the test, Val/Val 
subjects demonstrated a larger change score from 0-back to 1-
back, as compared to the Met/Met group. Since performance 
is expected to be worse at the more difﬁ  cult condition (ie, 
1-back) relative to the less demanding condition (ie, 0-back), 
this larger change score demonstrated by the Val/Val indi-
cates a greater decrease in accuracy from a less demanding 
condition to a more demanding condition. As such, the 
Val/Val subjects performed disproportionately worse as they 
progressed from 0-back to 1-back compared to the Met/Met 
group. Therefore, ﬁ  ndings of a larger change in performance 
0-back to 1-back in the Val/Val group provides evidence of 
working memory deﬁ  cits in those individuals, which is in line 
with previous ﬁ  ndings (Goldberg et al 2003). We propose 
that this method of examining working memory measured 
by the N-back may be of particular utility in future studies. 
In contrast, there was no signiﬁ  cant genotype difference for 
the change score from 0-back to 2-back, suggesting that the 
difﬁ  culty level in the 2-back condition may be too high for 
all participants and thus resulted in reduced sensitivity.
We predicted that the AX-CPT would be a more sensi-
tive task to detect effects of COMT in comparison to the 
N-back working memory task. COMT genotype explained 
comparable amounts of variance in both tasks (20%), but 
only with a different analytic plan than previously employed. 
Consistent with our hypothesis, processing speed and verbal 
working memory were not associated to the effects of COMT 
genotype.
A reformulation of the COMT genotype effect on cogni-
tion was recently provided by Bilder et al (2004), which sug-
gested that the functional effects of the COMT polymorphism 
may be better understood from the perspective of the tonic-
phasic DA theory. Bilder et al (2004) hypothesized that the 
Met allele is associated with increased tonic and decreased 
phasic DA transmission, leading to increased stability but 
reduced ﬂ  exibility of neural network activation states that are 
central to aspects of working memory. It was suggested that 
these effects may be beneﬁ  cial or detrimental depending the 
phenotype and environmental demands (ie, cognitive task). 
Thus, given our ﬁ  ndings, the AX-CPT and N-back may be 
DA-dependent tasks that require the stability of networks 
that underlies working memory, rather than the ﬂ  exibility 
of neural programming.
One major limitation of the current study relates to the 
small sample size. However, it should be noted that large 
effect sizes were found despite the small number of subjects. 
Future studies with a larger sample are needed to replicate 
the current ﬁ  ndings. Further, examination of diagnosis × 
genotype interactions would be of interest as well.
One interesting empirical question that the current ﬁ  nd-
ings point to is whether or not COMT genotype plays a 
signiﬁ  cant role in functional disability among patients with 
schizophrenia and schizotypal personality disorder. There is a 
substantial amount of evidence that schizophrenia is marked 
by profound functional impairments, including occupational 
(Carpenter and Strauss 1991; McGurk and Meltzer 2000) 
and social functioning (Mueser et al 1991; Green 1996; 
Green et al 2000). Further, across multiple studies, cognitive 
impairment has been found to be consistently related to work 
outcomes (Bryson et al 1998; McGurk and Meltzer 2000; 
Suslow et al 2000; Tsang et al 2000; Mueser et al 2001) 
and cognitive functioning uniquely predicted functional 
outcomes in patients (Green 1996) and individuals at risk for 
schizophrenia (Niendam et al 2006) over and above clini-
cal symptoms. Thus, it would be interesting to investigate 
whether COMT genotype mediates the relationship between 
cognitive deﬁ  cits and functional disability in patients with 
schizophrenia and schizotypal personality disorder.
In summary, preliminary results of the current study pro-
vided some evidence that context processing and working Neuropsychiatric Disease and Treatment 2007:3(6) 933
COMT Val158Met genotype and context processing
memory are associated with COMT genotype variation, 
and the AX-CPT and N-back are two theoretically dopa-
minergic dependent tasks most sensitive in capturing the 
effects of COMT. Processing speed and verbal working 
memory were not found to be related to COMT genotype 
in the current sample. Taken together, this study provides 
evidence that variation in COMT genotype does not lead 
to general impairment of cognitive functioning, but that it 
uniquely affects two speciﬁ  c prefrontal domains, context 
processing and working memory.
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